• N/A
    Market Cap
  • -100.00%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
09/30/2025
09/30/2024
Income Statement
Total Operating Revenue
9.8M
-14.71%
11.5M
N/A
Cost of Revenue
7.5M
-13.38%
8.6M
N/A
Gross Profit
2.3M
-18.25%
2.9M
N/A
Sales and Marketing Expense
2.1M
+1.23%
2.1M
N/A
Research and Development Expense
-435,311
+43.90%
-302,511
N/A
Depreciation and Amortization Expense
923,108
-34.55%
1.4M
N/A
Total Operating Expenses
4.8M
-29.98%
6.9M
N/A
Operating Profit
-1.1M
-70.48%
-3.7M
N/A
Interest Income
181,682
+1,449.26%
11,727
N/A
Interest Expense
-503,519
N/A
N/A
N/A
Interest Income and Expense and Net
-321,837
-2,844.41%
11,727
N/A
Total Nonoperating Income and Expense
1.4M
+272.63%
379,485
N/A
Income before Taxes
-1.1M
-70.48%
-3.7M
N/A
Income Taxes
119,053
+195.02%
-125,291
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-1.1M
-69.28%
-3.5M
N/A
Net Income from Continuing Operations Applicable to Common
-1.1M
-70.48%
-3.7M
N/A
Basic EPS and Net Income
-0.04
-85.19%
-0.27
N/A
Diluted EPS and Net Income
-0.04
-85.19%
-0.27
N/A
Basic Weighted Average Shares
29.0M
+128.12%
12.7M
N/A
Diluted Weighted Average Shares
29.0M
+128.12%
12.7M
N/A
Balance Sheet
Cash and Cash Equivalents
4.1M
-37.65%
6.6M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
4.1M
-37.65%
6.6M
N/A
Total Current Assets
20.5M
-1.79%
20.8M
N/A
Accumulated Depreciation
5.9M
+10.78%
5.4M
N/A
Property and Plant and Equipment and Net
10.6M
-6.90%
11.4M
N/A
Total Long-Term Assets
12.7M
-17.65%
15.4M
N/A
Total Assets
33.2M
-8.54%
36.3M
N/A
Income Taxes Payable
502,783
-1.17%
508,726
N/A
Total Short-Term Debt
6.4M
-52.03%
13.3M
N/A
Total Current Liabilities
12.0M
-40.68%
20.2M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
20,059
N/A
N/A
N/A
Total Liabilities
12.0M
-40.58%
20.2M
N/A
Retained Earnings
5.0M
-18.38%
6.1M
N/A
Total Stockholders Equity
18.3M
+39.08%
13.2M
N/A
Total Shares Outstanding
96.0M
+557.89%
14.6M
N/A
Cash Flow
Cash from Operating Activities
6.2M
+380.25%
-2.2M
N/A
Capital Expenditures
1.3M
-85.56%
9.2M
N/A
Cash from Investing Activities
-7.6M
-16.07%
-9.1M
N/A
Dividends Paid
N/A
N/A
2.8M
N/A
Cash from Financing Activities
-898,212
-105.74%
15.7M
N/A
Financials Ratio
Gross Margin
23.76%
N/A
N/A
N/A
Operating Margin
-11.02%
N/A
N/A
N/A
Return on Assets
-3.09%
N/A
N/A
N/A
Return on Equity
-6.81%
N/A
N/A
N/A
Revenue Growth
-14.71%
N/A
N/A
N/A
Current Ratio
1.71
N/A
N/A
N/A
Cash Ratio
0.34
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow